$BLUE Company News The State of Gene Therapy in
Post# of 102773
Posted On: 01/29/2014 11:58:48 AM
$BLUE Company News
The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron 8:00 a.m. Jan. 23, 2014 - TheStreet.com
J.P. Morgan Healthcare Confab Live Blog: Day Three 10:12 a.m. Jan. 15, 2014 - TheStreet.com
Bluebird Bio: 5 Different Insiders Have Sold Shares During The Last 30 Days 12:31 p.m. Jan. 13, 2014 - Seeking Alpha
22 Biotech Stock Predictions for 2014 7:58 a.m. Jan. 6, 2014 - TheStreet.com
Bluebird Biotechnology Lock Up Expiration May Cause Stock To Land 9:32 a.m. Dec. 5, 2013 - Seeking Alpha
Bluebird Bio Announces First Patient Transplanted in Phase 1/2 HGB-205 Beta-Thalassemia, Sickle Cell Anemia Study 5:48 a.m. Dec. 2, 2013 - benzinga.com
10-Q: BLUEBIRD BIO, INC. 4:22 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
The New Science Behind Medical Investing 3:27 a.m. Oct. 19, 2013 - Barrons.com
Healthcare Investors, Take Note of These Stem Cell Gems 1:10 p.m. Oct. 7, 2013 - Wall St. Cheat Sheet
The Hottest IPOs of 2013 4:43 a.m. Oct. 7, 2013 - 247WallSt.com
How High Will Bluebird Bio Fly? 1:36 p.m. Sept. 12, 2013 - Seeking Alpha
10-Q: BLUEBIRD BIO, INC. 5:00 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
bluebird bio Earnings: Everything You Must Know Now 4:43 p.m. Aug. 14, 2013 - Wall St. Cheat Sheet
The New IPO Boom 2:46 p.m. Aug. 5, 2013 - Barrons.com
Celgene Seen Widening Products Beyond Revlimid 9:39 a.m. July 17, 2013 - Investors Business Daily
UPDATE: J.P. Morgan Initiates bluebird bio at Overweight on Unique & Necessary Medical Products 6:56 a.m. July 15, 2013 - benzinga.com
UPDATE: Bank of America Initiates bluebird bio at Buy on Transformational Potential 6:26 a.m. July 15, 2013 - benzinga.com
Technology IPOs Showed Strongest First Day Pop In Q2 2:15 p.m. June 28, 2013 - Investors Business Daily
bluebird bio Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option 2:08 p.m. June 24, 2013 - benzinga.com
Closing Bell for Wednesday on Wall Street: Markets Open Low, Sink on FOMC Statement 3:23 p.m. June 19, 2013 - 247WallSt.com
Conferences, Preliminary Revenues, Board Changes, Shareholders' Meeting Results, and Clinical Trial Initiation - Research Report on Antares, Quidel, bluebird bio, Given Imaging, and Immunomedics 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
bluebird bio Appoints Dr James Mandell to its Board of Directors 6:30 a.m. Jan. 9, 2014 - BusinessWire
bluebird bio to Present at the J.P.Morgan Healthcare Conference 7:00 a.m. Jan. 8, 2014 - BusinessWire
bluebird bio Joins the NASDAQ Biotechnology Index 7:00 a.m. Dec. 26, 2013 - BusinessWire
Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio 8:00 a.m. Dec. 25, 2013 - PR Newswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
bluebird bio Announces First Patient Transplanted in Phase 1/2 HGB-205 Study for the Treatment of Beta-Thalassemia and Sickle Cell Anemia 6:45 a.m. Dec. 2, 2013 - BusinessWire
bluebird bio to Present at Deutsche Bank BioFEST Conference 7:00 a.m. Nov. 27, 2013 - BusinessWire
bluebird bio Reports Fiscal Third Quarter 2013 Financial Results 4:45 p.m. Nov. 14, 2013 - BusinessWire
bluebird bio Announces First Patient Transplanted in Phase 2/3 Starbeam ALD-102 Study for the Treatment of CCALD 6:39 a.m. Oct. 28, 2013 - BusinessWire
bluebird bio Joins the Russell 2000(R) Index 3:15 p.m. Oct. 1, 2013 - BusinessWire
Richard Morgan, Ph.D. Joins bluebird bio as Vice President of Immunotherapy 5:30 a.m. Oct. 1, 2013 - BusinessWire
Mast Therapeutics Hosting 2nd Annual Sickle Cell Disease Therapeutics Conference On September 19, 2013 7:00 a.m. Sept. 6, 2013 - PR Newswire
bluebird bio to Present at Morgan Stanley Global Healthcare Conference 5:00 a.m. Sept. 4, 2013 - BusinessWire
bluebird bio Selected As A 2014 Technology Pioneer By The World Economic Forum 4:30 a.m. Aug. 27, 2013 - BusinessWire
Wall Street Fundamentals Releases New In-Depth Stock Reports on BLUE, CMRX, CNAT and ICEL 7:51 a.m. Aug. 26, 2013 - ACCESSWIRE
bluebird bio Reports Fiscal Second Quarter 2013 Financial Results 3:05 p.m. Aug. 14, 2013 - BusinessWire
bluebird bio to Present at Two Upcoming Conferences 3:30 p.m. Aug. 6, 2013 - BusinessWire
RDInvesting Provides Investors with Free In-Depth Equity Reports on AXAS, BLUE, ONXX and TROV 7:43 a.m. July 16, 2013 - ACCESSWIRE
bluebird bio Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option 3:05 p.m. June 24, 2013 - BusinessWire
The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron 8:00 a.m. Jan. 23, 2014 - TheStreet.com
J.P. Morgan Healthcare Confab Live Blog: Day Three 10:12 a.m. Jan. 15, 2014 - TheStreet.com
Bluebird Bio: 5 Different Insiders Have Sold Shares During The Last 30 Days 12:31 p.m. Jan. 13, 2014 - Seeking Alpha
22 Biotech Stock Predictions for 2014 7:58 a.m. Jan. 6, 2014 - TheStreet.com
Bluebird Biotechnology Lock Up Expiration May Cause Stock To Land 9:32 a.m. Dec. 5, 2013 - Seeking Alpha
Bluebird Bio Announces First Patient Transplanted in Phase 1/2 HGB-205 Beta-Thalassemia, Sickle Cell Anemia Study 5:48 a.m. Dec. 2, 2013 - benzinga.com
10-Q: BLUEBIRD BIO, INC. 4:22 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
The New Science Behind Medical Investing 3:27 a.m. Oct. 19, 2013 - Barrons.com
Healthcare Investors, Take Note of These Stem Cell Gems 1:10 p.m. Oct. 7, 2013 - Wall St. Cheat Sheet
The Hottest IPOs of 2013 4:43 a.m. Oct. 7, 2013 - 247WallSt.com
How High Will Bluebird Bio Fly? 1:36 p.m. Sept. 12, 2013 - Seeking Alpha
10-Q: BLUEBIRD BIO, INC. 5:00 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
bluebird bio Earnings: Everything You Must Know Now 4:43 p.m. Aug. 14, 2013 - Wall St. Cheat Sheet
The New IPO Boom 2:46 p.m. Aug. 5, 2013 - Barrons.com
Celgene Seen Widening Products Beyond Revlimid 9:39 a.m. July 17, 2013 - Investors Business Daily
UPDATE: J.P. Morgan Initiates bluebird bio at Overweight on Unique & Necessary Medical Products 6:56 a.m. July 15, 2013 - benzinga.com
UPDATE: Bank of America Initiates bluebird bio at Buy on Transformational Potential 6:26 a.m. July 15, 2013 - benzinga.com
Technology IPOs Showed Strongest First Day Pop In Q2 2:15 p.m. June 28, 2013 - Investors Business Daily
bluebird bio Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option 2:08 p.m. June 24, 2013 - benzinga.com
Closing Bell for Wednesday on Wall Street: Markets Open Low, Sink on FOMC Statement 3:23 p.m. June 19, 2013 - 247WallSt.com
Conferences, Preliminary Revenues, Board Changes, Shareholders' Meeting Results, and Clinical Trial Initiation - Research Report on Antares, Quidel, bluebird bio, Given Imaging, and Immunomedics 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
bluebird bio Appoints Dr James Mandell to its Board of Directors 6:30 a.m. Jan. 9, 2014 - BusinessWire
bluebird bio to Present at the J.P.Morgan Healthcare Conference 7:00 a.m. Jan. 8, 2014 - BusinessWire
bluebird bio Joins the NASDAQ Biotechnology Index 7:00 a.m. Dec. 26, 2013 - BusinessWire
Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio 8:00 a.m. Dec. 25, 2013 - PR Newswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
bluebird bio Announces First Patient Transplanted in Phase 1/2 HGB-205 Study for the Treatment of Beta-Thalassemia and Sickle Cell Anemia 6:45 a.m. Dec. 2, 2013 - BusinessWire
bluebird bio to Present at Deutsche Bank BioFEST Conference 7:00 a.m. Nov. 27, 2013 - BusinessWire
bluebird bio Reports Fiscal Third Quarter 2013 Financial Results 4:45 p.m. Nov. 14, 2013 - BusinessWire
bluebird bio Announces First Patient Transplanted in Phase 2/3 Starbeam ALD-102 Study for the Treatment of CCALD 6:39 a.m. Oct. 28, 2013 - BusinessWire
bluebird bio Joins the Russell 2000(R) Index 3:15 p.m. Oct. 1, 2013 - BusinessWire
Richard Morgan, Ph.D. Joins bluebird bio as Vice President of Immunotherapy 5:30 a.m. Oct. 1, 2013 - BusinessWire
Mast Therapeutics Hosting 2nd Annual Sickle Cell Disease Therapeutics Conference On September 19, 2013 7:00 a.m. Sept. 6, 2013 - PR Newswire
bluebird bio to Present at Morgan Stanley Global Healthcare Conference 5:00 a.m. Sept. 4, 2013 - BusinessWire
bluebird bio Selected As A 2014 Technology Pioneer By The World Economic Forum 4:30 a.m. Aug. 27, 2013 - BusinessWire
Wall Street Fundamentals Releases New In-Depth Stock Reports on BLUE, CMRX, CNAT and ICEL 7:51 a.m. Aug. 26, 2013 - ACCESSWIRE
bluebird bio Reports Fiscal Second Quarter 2013 Financial Results 3:05 p.m. Aug. 14, 2013 - BusinessWire
bluebird bio to Present at Two Upcoming Conferences 3:30 p.m. Aug. 6, 2013 - BusinessWire
RDInvesting Provides Investors with Free In-Depth Equity Reports on AXAS, BLUE, ONXX and TROV 7:43 a.m. July 16, 2013 - ACCESSWIRE
bluebird bio Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option 3:05 p.m. June 24, 2013 - BusinessWire
(0)
(0)